{
    "clinical_study": {
        "@rank": "125952", 
        "acronym": "SEWORRA", 
        "arm_group": {
            "arm_group_label": "rituximab", 
            "arm_group_type": "Experimental", 
            "description": "Only one arm; all patients are treated by rituximab (monotherapy or in combination with conventional DMARD)"
        }, 
        "brief_summary": {
            "textblock": "To detect by sonography relapse of disease activity prior to clinical symptoms in RA\n      patients treated by rituximab."
        }, 
        "brief_title": "Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  failure to at least one TNF-blocking agent\n\n        Exclusion Criteria:\n\n          -  pregnant or childbearing woman\n\n          -  Rituximab contraindication\n\n          -  woman unable to use contraceptive means"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 12, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765374", 
            "org_study_id": "2010/081/HP"
        }, 
        "intervention": [
            {
                "arm_group_label": "rituximab", 
                "description": "US evaluation at different time points", 
                "intervention_name": "ESAOTE MyLab60", 
                "intervention_type": "Device", 
                "other_name": "sonography"
            }, 
            {
                "arm_group_label": "rituximab", 
                "intervention_name": "Rituximab", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rituximab"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "rituximab", 
            "sonography", 
            "clinical response"
        ], 
        "lastchanged_date": "January 9, 2013", 
        "location": [
            {
                "contact": {
                    "email": "marcelli-c@chu-caen.fr", 
                    "last_name": "Christian Marcelli, MD", 
                    "phone": "33 2 31 06 31 06"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14033"
                    }, 
                    "name": "Department of Rheumatology, CHU de Caen"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caen, Le Havre, Rouen, Elbeuf", 
                        "country": "France"
                    }, 
                    "name": "Normandy"
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "contact": {
                    "email": "czarnitsky@ch-havre.fr", 
                    "last_name": "Charles Zarnitsky", 
                    "phone": "33 2 32 73 32 32"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Havre", 
                        "country": "France", 
                        "zip": "76290"
                    }, 
                    "name": "Department of Rheumatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "olivier.vittecoq@chu-rouen.fr", 
                    "last_name": "Olivier Vittecoq, MD,PhD", 
                    "phone": "33 2 32 88 90 19"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76031"
                    }, 
                    "name": "Department of rheumatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fernando.dasilva@chi-elbeuf-louviers.fr", 
                    "last_name": "Frenando da Silva, MD", 
                    "phone": "33 2 32 96 35 35"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Aubin Les Elbeuf", 
                        "country": "France", 
                        "zip": "76410"
                    }, 
                    "name": "Department of Rheumatology CHG Elbeuf"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis", 
        "overall_contact": {
            "email": "olivier.vittecoq@chu-rouen.fr", 
            "last_name": "Olivier Vittecoq, MD,PHD", 
            "phone": "+33 2 32 88 90 19"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Each time point will be assessed since the main objective of the study is to detect the time of sonographic relapse prior to clinical relapse", 
            "measure": "global score of power-doppler activity measured by ultrasonography on 12 joints", 
            "safety_issue": "No", 
            "time_frame": "at 6 months after initiation of rituximab and then every 2 month over the follow-up period (18 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765374"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Rouen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Rouen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}